River & Mercantile Asset Management LLP Chembio Diagnostics, Inc. Transaction History

River & Mercantile Asset Management LLP

  • $459 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 27, 2019
BUY
$5.56 - $7.85 $858,502 - $1.21 Million
154,407 New
154,407 $940,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track River & Mercantile Asset Management LLP Portfolio

Follow River & Mercantile Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River & Mercantile Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on River & Mercantile Asset Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email